Repair and tissue engineering techniques for articular cartilage

Eleftherios A. Makris, Andreas H. Gomoll, Konstantinos N. Malizos, Jerry C. Hu, Kyriacos A. Athanasiou

Research output: Contribution to journalArticle

351 Citations (Scopus)

Abstract

Chondral and osteochondral lesions due to injury or other pathology commonly result in the development of osteoarthritis, eventually leading to progressive total joint destruction. Although current progress suggests that biologic agents can delay the advancement of deterioration, such drugs are incapable of promoting tissue restoration. The limited ability of articular cartilage to regenerate renders joint arthroplasty an unavoidable surgical intervention. This Review describes current, widely used clinical repair techniques for resurfacing articular cartilage defects; short-term and long-term clinical outcomes of these techniques are discussed. Also reviewed is a developmental pipeline of acellular and cellular regenerative products and techniques that could revolutionize joint care over the next decade by promoting the development of functional articular cartilage. Acellular products typically consist of collagen or hyaluronic-acid-based materials, whereas cellular techniques use either primary cells or stem cells, with or without scaffolds. Central to these efforts is the prominent role that tissue engineering has in translating biological technology into clinical products; therefore, concomitant regulatory processes are also discussed.

Original languageEnglish (US)
Pages (from-to)21-34
Number of pages14
JournalNature Reviews Rheumatology
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Articular Cartilage
Tissue Engineering
Joints
Biological Factors
Hyaluronic Acid
Osteoarthritis
Arthroplasty
Cartilage
Collagen
Stem Cells
Pathology
Technology
Wounds and Injuries
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Rheumatology

Cite this

Makris, E. A., Gomoll, A. H., Malizos, K. N., Hu, J. C., & Athanasiou, K. A. (2015). Repair and tissue engineering techniques for articular cartilage. Nature Reviews Rheumatology, 11(1), 21-34. https://doi.org/10.1038/nrrheum.2014.157

Repair and tissue engineering techniques for articular cartilage. / Makris, Eleftherios A.; Gomoll, Andreas H.; Malizos, Konstantinos N.; Hu, Jerry C.; Athanasiou, Kyriacos A.

In: Nature Reviews Rheumatology, Vol. 11, No. 1, 01.01.2015, p. 21-34.

Research output: Contribution to journalArticle

Makris, EA, Gomoll, AH, Malizos, KN, Hu, JC & Athanasiou, KA 2015, 'Repair and tissue engineering techniques for articular cartilage', Nature Reviews Rheumatology, vol. 11, no. 1, pp. 21-34. https://doi.org/10.1038/nrrheum.2014.157
Makris, Eleftherios A. ; Gomoll, Andreas H. ; Malizos, Konstantinos N. ; Hu, Jerry C. ; Athanasiou, Kyriacos A. / Repair and tissue engineering techniques for articular cartilage. In: Nature Reviews Rheumatology. 2015 ; Vol. 11, No. 1. pp. 21-34.
@article{9628fa79053f4d92a0eccab2bc69863e,
title = "Repair and tissue engineering techniques for articular cartilage",
abstract = "Chondral and osteochondral lesions due to injury or other pathology commonly result in the development of osteoarthritis, eventually leading to progressive total joint destruction. Although current progress suggests that biologic agents can delay the advancement of deterioration, such drugs are incapable of promoting tissue restoration. The limited ability of articular cartilage to regenerate renders joint arthroplasty an unavoidable surgical intervention. This Review describes current, widely used clinical repair techniques for resurfacing articular cartilage defects; short-term and long-term clinical outcomes of these techniques are discussed. Also reviewed is a developmental pipeline of acellular and cellular regenerative products and techniques that could revolutionize joint care over the next decade by promoting the development of functional articular cartilage. Acellular products typically consist of collagen or hyaluronic-acid-based materials, whereas cellular techniques use either primary cells or stem cells, with or without scaffolds. Central to these efforts is the prominent role that tissue engineering has in translating biological technology into clinical products; therefore, concomitant regulatory processes are also discussed.",
author = "Makris, {Eleftherios A.} and Gomoll, {Andreas H.} and Malizos, {Konstantinos N.} and Hu, {Jerry C.} and Athanasiou, {Kyriacos A.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1038/nrrheum.2014.157",
language = "English (US)",
volume = "11",
pages = "21--34",
journal = "Nature reviews. Rheumatology",
issn = "1759-4790",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Repair and tissue engineering techniques for articular cartilage

AU - Makris, Eleftherios A.

AU - Gomoll, Andreas H.

AU - Malizos, Konstantinos N.

AU - Hu, Jerry C.

AU - Athanasiou, Kyriacos A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Chondral and osteochondral lesions due to injury or other pathology commonly result in the development of osteoarthritis, eventually leading to progressive total joint destruction. Although current progress suggests that biologic agents can delay the advancement of deterioration, such drugs are incapable of promoting tissue restoration. The limited ability of articular cartilage to regenerate renders joint arthroplasty an unavoidable surgical intervention. This Review describes current, widely used clinical repair techniques for resurfacing articular cartilage defects; short-term and long-term clinical outcomes of these techniques are discussed. Also reviewed is a developmental pipeline of acellular and cellular regenerative products and techniques that could revolutionize joint care over the next decade by promoting the development of functional articular cartilage. Acellular products typically consist of collagen or hyaluronic-acid-based materials, whereas cellular techniques use either primary cells or stem cells, with or without scaffolds. Central to these efforts is the prominent role that tissue engineering has in translating biological technology into clinical products; therefore, concomitant regulatory processes are also discussed.

AB - Chondral and osteochondral lesions due to injury or other pathology commonly result in the development of osteoarthritis, eventually leading to progressive total joint destruction. Although current progress suggests that biologic agents can delay the advancement of deterioration, such drugs are incapable of promoting tissue restoration. The limited ability of articular cartilage to regenerate renders joint arthroplasty an unavoidable surgical intervention. This Review describes current, widely used clinical repair techniques for resurfacing articular cartilage defects; short-term and long-term clinical outcomes of these techniques are discussed. Also reviewed is a developmental pipeline of acellular and cellular regenerative products and techniques that could revolutionize joint care over the next decade by promoting the development of functional articular cartilage. Acellular products typically consist of collagen or hyaluronic-acid-based materials, whereas cellular techniques use either primary cells or stem cells, with or without scaffolds. Central to these efforts is the prominent role that tissue engineering has in translating biological technology into clinical products; therefore, concomitant regulatory processes are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=84926337395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926337395&partnerID=8YFLogxK

U2 - 10.1038/nrrheum.2014.157

DO - 10.1038/nrrheum.2014.157

M3 - Article

C2 - 25247412

AN - SCOPUS:84926337395

VL - 11

SP - 21

EP - 34

JO - Nature reviews. Rheumatology

JF - Nature reviews. Rheumatology

SN - 1759-4790

IS - 1

ER -